Cargando…
Novel Role of Gestational Hydralazine in Limiting Maternal and Dietary Obesity-Related Chronic Kidney Disease
BACKGROUND: Maternal obesity is a risk factor for chronic kidney disease (CKD) in offspring, underpinning the theory of the developmental origins of health and disease. DNA methylation has been implicated in the programming of adult chronic disease by maternal obesity, therefore, DNA demethylating a...
Autores principales: | Larkin, Benjamin P., Nguyen, Long T., Hou, Miao, Glastras, Sarah J., Chen, Hui, Wang, Rosy, Pollock, Carol A., Saad, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416283/ https://www.ncbi.nlm.nih.gov/pubmed/34485290 http://dx.doi.org/10.3389/fcell.2021.705263 |
Ejemplares similares
-
Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet
por: Larkin, Benjamin P., et al.
Publicado: (2021) -
Low‐dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity‐related chronic kidney disease
por: Larkin, Benjamin P., et al.
Publicado: (2022) -
Diet Modification before or during Pregnancy on Maternal and Foetal Outcomes in Rodent Models of Maternal Obesity
por: Rodrigo, Natassia, et al.
Publicado: (2022) -
Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring
por: Glastras, Sarah J., et al.
Publicado: (2018) -
FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity
por: Glastras, Sarah J., et al.
Publicado: (2015)